跳至主要内容
临床试验/NCT00619034
NCT00619034已完成不适用

Pharmacological Intervention Against Diabetic Retinal Flow Disturbances.

University of Aarhus1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2007年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
87
试验地点
1
主要终点
Diameter of retinal blood vessels

研究概览

简要总结

The purpose of this study is to determine if diabetic retinopathy can be treated with prostaglandin analogues, prostaglandin synthesis inhibitors or carbonic anhydrases inhibitors.

详细描述

Disturbances in retinal perfusion is believed to be involved in the pathophysiology of diabetic retinopathy. These disturbances may be due to changes in the basal diameter of retinal arterioles and to disturbances in the autoregulation of the diameter of these vessels when the blood pressure and the retinal metabolism changes. In vitro studies have shown that prostaglandins and carbonic anhydrases inhibitors are involved in the tone regulation of retinal arterioles, but it is unknown whether this finding is relevant in clinical practice. This can be tested in vivo by an retinal vessel analyzer measuring the dynamics of the retinal vessel diameter changes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes type 1 with moderate diabetic retinopathy/healthy
  • Blood pressure < 135/85 mmHg

排除标准

  • Eye disease (excluding diabetic retinopathy)
  • Kidney disease
  • Liver disease
  • Severe asthma
  • Heart disease
  • Hypertension arterial
  • Users of drugs that influence the metabolism of the prostaglandins in the carbon dioxide
  • Pregnant and breastfeeding women and women who don't use secure contraception
  • Persons who can't do without contact lens in the treated eye.

研究组 & 干预措施

latanoprost

Experimental

Medical intervention cross-over

干预措施: Latanoprost, diclofenac and dorzolamide (eyedrops) (Drug)

diclofenac

Active Comparator

medical intervention

干预措施: Diclofenac (Drug)

dorzolamide

Experimental

dorzolamide eyedrops twice daily in one week

干预措施: Dorzolamide (Drug)

结局指标

主要结局

Diameter of retinal blood vessels

时间窗: one year

次要结局

  • Influence on retinal blood flow in diabetes(one year)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Pharmacological Intervention in Diabetic Retinopathy | 临床试验